Present and future treatment of pancreatic cancer

被引：46

作者：

Heinemann, V ^{[1
]}

机构：

[1] Univ Munich, Dept Hematol Oncol, Klinikum Grosshadern, D-81377 Munich, Germany

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.34269

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：23 / 31

页数：9

相关论文

共 62 条

[1] ABBRUZZESE JL, 2001, P AN M AM SOC CLIN, V20, pA518
[2] ALABISO O, 2001, P AN M AM SOC CLIN, V20, pA2331
[3] ANCHISI S, 2000, P AN M AM SOC CLIN, V19, pA1280
[4] BERLIN J, 2001, P AN M AM SOC CLIN, V20, pA505
[5] A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296)
Berlin, JD
Adak, S
Vaughn, DJ
Flinker, D
Blaszkowsky, L
Harris, JE
Benson, AB
[J]. ONCOLOGY, 2000, 58 (03) : 215 - 218
[6] Marimastat as first-line therapy for patients with unresectable pancreatic cancer: A randomized trial
Bramhall, SR
Rosemurgy, A
Brown, PD
Bowry, C
Buckels, JAC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (15) : 3447 - 3455
[7] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
Burris, HA
Moore, MJ
Andersen, J
Green, MR
Rothenberg, ML
Madiano, MR
Cripps, MC
Portenoy, RK
Storniolo, AM
Tarassoff, P
Nelson, R
Dorr, FA
Stephens, CD
VanHoff, DD
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2403 - 2413
[8] CAMPOS LT, 2001, P AN M AM SOC CLIN, V20, pA2315
[9] CAO MG, 2001, P AN M AM SOC CLIN, V20, pA2274
[10] Phase II study of gemcitabine in patients with advanced pancreatic cancer
Carmichael, J
Fink, U
Russell, RCG
Spittle, MF
Harris, AL
Spiessi, G
Blatter, J
[J]. BRITISH JOURNAL OF CANCER, 1996, 73 (01) : 101 - 105

← 1 2 3 4 5 6 7 →